Common Contracts

CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍ

Clinical Trial Agreement • March 30th, 2020

• Contract Type
  Clinical Trial Agreement
• Filed
  March 30th, 2020

 Arena Pharmaceuticals, Inc., having a place of business at 6154 Nancy Ridge Drive, San Diego, CA 92121, USA, Federal Tax ID: 23-2908305 (the “Sponsor”); and

Clinical Trial Agreement smlouva o klinickém hodnocení

Clinical Trial Agreement • March 3rd, 2020

• Contract Type
  Clinical Trial Agreement
• Filed
  March 3rd, 2020

• Arena Pharmaceuticals, Inc., having a place of business at 6154 Nancy Ridge Drive, San Diego, CA 92121, USA Federal Tax ID: 23-2908305 (the “Sponsor”); and

Contract

Clinical Trial Agreement • February 13th, 2020

• Contract Type
  Clinical Trial Agreement
• Filed
  February 13th, 2020

Clinical Trial Agreement No. 017/OVZ/20/006-P Smlouva o klinickém hodnoceníČ. 017/OVZ/20/006-P The Clinical Trial Agreement (“Agreement”) is made by and among: Tato smlouva o klinickém hodnocení („Smlouva“) je uzavírána mezi následujícími stranami: • Arena Pharmaceuticals, Inc., having a place of business at 6154 Nancy Ridge Drive, San Diego, CA 92121, USA, VAT number: 232908305 (the “Sponsor”); and • Arena Pharmaceuticals, Inc., se sídlem 6154 Nancy Ridge Drive, San Diego, CA 92121, USA, DIČ: 232908305(„Zadavatel“); a • Fakultní nemocnice Ostrava, having a place of business at 17. listopadu 1790/5, Poruba, 708 52 Ostrava, Czech Republic, Identification number: 00843989, Tax identification number: CZ00843989, Foundation Decree of the Ministry of Health of the Czech Republic dated 25 Nov 1990 no. OP-054-25.11.90, represented by doc. MUDr. Petr Vávra, Ph.D., Deputy Director for Science and Research (the “Institution”); and • Fakultní nemocnice Ostrava, se sídlem 17. listopadu 1790/5, Por